Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes ME Gaillard, D Bottero, A Errea, M Ormazábal, ME Zurita, G Moreno, ... Vaccine 32 (8), 931-937, 2014 | 82 | 2014 |
Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina G Fabricius, PE Bergero, ME Ormazabal, AL Maltz, DF Hozbor Epidemiology & Infection 141 (4), 718-734, 2013 | 35 | 2013 |
Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles M Ormazábal, E Bartel, ME Gaillard, D Bottero, A Errea, ME Zurita, ... Vaccine 32 (46), 6084-6090, 2014 | 30 | 2014 |
Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease AN Crivaro, JM Mucci, CM Bondar, ME Ormazabal, R Ceci, C Simonaro, ... Plos one 14 (5), e0217780, 2019 | 20 | 2019 |
CRISPR/Cas9 editing for gaucher disease modelling E Pavan, M Ormazabal, P Peruzzo, E Vaena, P Rozenfeld, A Dardis International Journal of Molecular Sciences 21 (9), 3268, 2020 | 18 | 2020 |
The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production E Zurita, G Moreno, A Errea, M Ormazabal, M Rumbo, D Hozbor Infection and immunity 81 (7), 2371-2378, 2013 | 14 | 2013 |
In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase C Bondar, J Mucci, A Crivaro, M Ormazabal, R Ceci, B Oliveri, D González, ... Bone 103, 262-269, 2017 | 13 | 2017 |
Osteocyte alterations induce osteoclastogenesis in an in vitro model of gaucher disease C Bondar, M Ormazabal, A Crivaro, M Ferreyra-Compagnucci, ... International Journal of Molecular Sciences 18 (1), 112, 2017 | 11 | 2017 |
Plasma neurofilament light (NfL) in patients affected by niemann–pick type C disease (NPCD) A Dardis, E Pavan, M Fabris, RM Da Riol, A Sechi, A Fiumara, L Santoro, ... Journal of Clinical Medicine 10 (20), 4796, 2021 | 9 | 2021 |
Unraveling the mystery of Gaucher bone density pathophysiology PA Rozenfeld, AN Crivaro, M Ormazabal, JM Mucci, C Bondar, ... Molecular Genetics and Metabolism 132 (2), 76-85, 2021 | 8 | 2021 |
Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis A Crivaro, C Bondar, JM Mucci, M Ormazabal, RA Feldman, MV Delpino, ... Molecular Genetics and Metabolism 130 (4), 274-282, 2020 | 8 | 2020 |
Corrigendum to" Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased … A Crivaro, C Bondar, JM Mucci, M Ormazabal, RA Feldman, MV Delpino, ... Molecular genetics and metabolism 131 (1-2), 286, 2020 | 1 | 2020 |
MPS II models for the study of joint and bone pathophysiology using CRISPR/Cas9 technology E Vaena, ME Ormazabal, R Ceci, P Domingo, PA Rozenfeld, A Dardis Molecular Genetics and Metabolism 141 (2), 108060, 2024 | | 2024 |
Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease A Crivaro, JM Mucci, C Bondar, M Ormazabal, E Vaena, MV Delpino, ... Molecular Genetics and Metabolism Reports 36, 100980, 2023 | | 2023 |
Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology ME Ormazabal, E Pavan, E Vaena, D Ferino, J Biasizzo, JM Mucci, ... International Journal of Molecular Sciences 24 (13), 11204, 2023 | | 2023 |
Lyso-Gb3 determination in classic and late onset Fabry patients PA Rozenfeld, R Ceci, A Velazco, E Vaena, AN Crivaro, JM Mucci, ... Molecular Genetics and Metabolism 138 (2), 107299, 2023 | | 2023 |
Generation of an in vitro model for Hunter syndrome using CRISPR/Cas9 technology E Vaena, ME Ormazabal, E Pavan, JM Mucci, AN Crivaro, C Bondar, ... Molecular Genetics and Metabolism 138 (2), 107339, 2023 | | 2023 |
Expression of caspase-3 and TGF-β1 in Fabry disease biopsies: Correlation with clinical parameters C Bondar, JM Mucci, AN Crivaro, E Vaena, ME Ormazabal, PA Rozenfeld Molecular Genetics and Metabolism 138 (2), 107033, 2023 | | 2023 |
Gaucher disease mesenchymal stem cells showed reduced osteogenesis and increased osteoclastogenesis and adipogenesis P Rozenfeld, A Crivaro, C Bondar, JM Mucci, M Ormazabal, R Feldman, ... Molecular Genetics and Metabolism 132 (2), S92, 2021 | | 2021 |
Evaluation of PPS treatment in osteoclast-osteoblast imbalance using in vitro models of Gaucher disease JM Mucci, C Bondar, A Crivaro, M Ormazabal, E Schuchman, C Simonaro, ... Molecular Genetics and Metabolism 126 (2), S103, 2019 | | 2019 |